Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

NCT00080002 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

INDUSTRY

Sponsor class

Conditions

Cancer of Stomach
Gastroesophageal Cancer

Interventions

DRUG: Pegamotecan

Sponsor

Enzon Pharmaceuticals, Inc.